Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel

被引:79
作者
Davidovici, B
Karakis, I
Bourboulia, D
Ariad, S
Zong, JC
Benharroch, D
Dupin, N
Weiss, R
Hayward, G
Sarov, B [1 ]
Boshoff, C
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Soroka Univ Med Ctr, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Oncol, Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Pathol, Beer Sheva, Israel
[4] UCL, Canc Res Campaign, Viral Oncol Grp, Dept Oncol, London, England
[5] UCL, Canc Res Campaign, Dept Mol Pathol, London, England
[6] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 03期
关键词
D O I
10.1093/jnci/93.3.194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of classic Kaposi's sarcoma among Jews in Israel is among the highest in the developed world. Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) is causally linked to Kaposi's sarcoma, Very little is known about the prevalence of KSHV in the Middle East or about the modes of transmission in Mediterranean countries. Methods: From 1992 through 1995, sera were obtained from 1648 adults who had tested positive for hepatitis B virus (HBV) surface antigen 20 years earlier at blood donations; sera were also obtained from 2403 of their family members. All sera were tested for anti-KSHV antibodies with the use of an indirect immunofluorescence assay. To analyze the effects of various factors on the risk of KSHV infection for both the HBV-positive cohort and their families, logistic regression for cluster data and generalized estimating equations were used. All statistical tests were two-sided. Results: Among family members, the seroprevalence of antibodies against KSHV was 9.9% (95% confidence interval [CI] = 8.7% to 11.1%); among the former blood donors who had tested positive for hepatitis B, it was 22% (95% CI = 19.9% to 24.1%), Overall, the best predictor of KSHV status was the place of birth. The most important risk factors found for both husband and wife to test KSHV positive were their own places of birth and their spouse's seropositivity. For a child to test positive, the most important risk factor was maternal seropositivity. Conclusions: The crude prevalence rate of KSHV among the Jewish population in Israel is 9.9%, Important routes of KSHV transmission in the families studied are spouse to spouse and mother to child, The presence of KSHV in Jews in Israel of all ethnic origins and their high incidence of reported Kaposi's sarcoma suggest that KSHV was introduced into the Jewish population prior to the major Diaspora.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 55 条
  • [21] 2-E
  • [22] Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): Analysis of seroconversions to ORF65 and ORF73
    Goudsmit, J
    Renwick, N
    Dukers, NHTM
    Coutinho, RA
    Heisterkamp, S
    Bakker, M
    Schulz, TF
    Cornelissen, M
    Weverling, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) : 4838 - 4843
  • [23] KAPOSI-SARCOMA IN ENGLAND AND WALES BEFORE THE AIDS EPIDEMIC
    GRULICH, AE
    BERAL, V
    SWERDLOW, AJ
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 (06) : 1135 - 1137
  • [24] KSHV strains: the origins and global spread of the virus
    Hayward, GS
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 187 - 199
  • [25] Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS
    He, J
    Bhat, G
    Kankasa, C
    Chintu, C
    Mitchell, C
    Duan, WJ
    Wood, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) : 1787 - 1790
  • [26] Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors
    Howard, MR
    Whitby, D
    Bahadur, G
    Suggett, F
    Boshoff, C
    TenantFlowers, M
    Schulz, TF
    Kirk, S
    Matthews, S
    Weller, IVD
    Tedder, RS
    Weiss, RA
    [J]. AIDS, 1997, 11 (02) : F15 - F19
  • [27] Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study
    Iscovich, J
    Boffetta, P
    Winkelmann, R
    Brennan, P
    Azizi, E
    [J]. AIDS, 1998, 12 (15) : 2067 - 2072
  • [28] Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma
    Katano, H
    Iwasaki, T
    Baba, N
    Terai, M
    Mori, S
    Iwamoto, A
    Kurata, T
    Sata, T
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (08) : 3478 - 3485
  • [29] The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women
    Kedes, DH
    Ganem, D
    Ameli, N
    Bacchetti, P
    Greenblatt, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06): : 478 - 481
  • [30] The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
    Kedes, DH
    Operskalski, E
    Busch, M
    Kohn, R
    Flood, J
    Ganem, D
    [J]. NATURE MEDICINE, 1996, 2 (08) : 918 - 924